Sientra Inc (SIEN.OQ)
24.09USD
17 Oct 2018
$0.00 (+0.00%)
$24.09
$23.77
$24.17
$23.18
45,285
119,337
$26.79
$8.79
About
Overall
| Beta: | -- |
| Market Cap(Mil.): | $307.56 |
| Shares Outstanding(Mil.): | 19.31 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| SIEN.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 32.37 | 33.73 |
| EPS (TTM): | -2.66 | -- | -- |
| ROI: | -61.89 | 14.01 | 14.31 |
| ROE: | -64.43 | 16.77 | 16.04 |
SEC sues U.S. breast-implant company's ex-CEO after stock dive
The U.S. Securities and Exchange Commission on Wednesday sued the founder and former chief executive of Sientra Inc for fraudulently concealing problems with his company's breast and other implants as it was raising $61.4 million in a public stock offering.
UPDATE 1-SEC sues U.S. breast-implant company's ex-CEO after stock dive
Sept 19 The U.S. Securities and Exchange Commission on Wednesday sued the founder and former chief executive of Sientra Inc for fraudulently concealing problems with his company's breast and other implants as it was raising $61.4 million in a public stock offering.
SEC sues ex-CEO of California breast implant company after stock nosedived
Sept 19 The U.S. Securities and Exchange Commission on Wednesday sued the founder and former chief executive of Sientra Inc for fraudulently concealing problems with his company's breast and other implants as it was raising $61.4 million in a public stock offering.
BRIEF-Sientra Q1 Loss Per Share $0.99
* Q1 EARNINGS PER SHARE VIEW $-0.84 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:
BRIEF-Sientra Inc. Announces Closing Of $115 Mln Public Offering Of Common Stock
* SIENTRA, INC. ANNOUNCES CLOSING OF $115 MILLION PUBLIC OFFERING OF COMMON STOCK AND EXERCISE IN FULL OF UNDERWRITERS’ OVER-ALLOTMENT OPTION Source text for Eikon: Further company coverage:
BRIEF-Sientra Announces Pricing Of Upsized Public Offering Of Common Stock
* SIENTRA ANNOUNCES PRICING OF UPSIZED PUBLIC OFFERING OF COMMON STOCK
BRIEF-Sientra Inc Says Commenced Underwritten Public Follow-On Offering Of About $75 Mln Of Its Stock To Be Sold By Co
* SIENTRA INC - COMMENCED UNDERWRITTEN PUBLIC FOLLOW-ON OFFERING OF ABOUT $75 MILLION OF ITS STOCK TO BE SOLD BY COMPANY
BRIEF-Sientra Sees Preliminary Unaudited Net Sales For Q1 2018 Of About $14.5 Mln
* SIENTRA INC - SEES PRELIMINARY UNAUDITED NET SALES FOR Q1 2018 OF ABOUT $14.5 MILLION
BRIEF-Sientra Receives FDA Approval Of PMA Supplement
* SIENTRA INC - ADDITIONAL $10 MILLION OF EXISTING CREDIT FACILITY NOW ACCESSIBLE WITH FDA APPROVAL
Competitors
| Price | Chg | |
|---|---|---|
| Allergan plc (AGN.N) | $191.00 | +3.01 |
| Johnson & Johnson (JNJ.N) | $139.46 | +2.90 |
Estimates